Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization

R Moghnieh, W Haddad, N Jbeily, S El-Hassan, S Eid… - PloS one, 2024 - journals.plos.org
In this study, we conducted a case-control investigation to assess the immunogenicity and
effectiveness of primary and first booster homologous and heterologous COVID-19 …

Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a cross-sectional survey

Y Zou, J Xu, AJ Chen, K Huang, SM Zhu, JJ Li, J He… - Scientific Reports, 2024 - nature.com
In this study we aimed to investigate the prevalence of SARS-CoV-2 infection in psoriasis
patients, and outcomes of SARS-CoV-2 infection and associated risk factors. A cross …

Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD–ACE2 and TMPRRS2 proteins

MJ Shayo, B Samwel, DM Shadrack, J Cassel… - RSC …, 2024 - pubs.rsc.org
The coronavirus disease 2019 (COVID-19) has spread worldwide with severe health, social,
and economic repercussions. Although vaccines have significantly reduced the severity of …

Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain

VL de Rioja, L Basile, A Perramon-Malavez… - Vaccines, 2024 - mdpi.com
In the current COVID-19 landscape dominated by Omicron subvariants, understanding the
timing and efficacy of vaccination against emergent lineages is crucial for planning future …

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post …

Z Sezer, STI Pavel, A Inal, H Yetiskin, B Kaplan… - Vaccines, 2024 - mdpi.com
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated
the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label …

[HTML][HTML] Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao

XZ Zhang, PHH Wong, KS Lai, B Yang, M Song, J Li… - Vaccines, 2024 - mdpi.com
Monitoring the effectiveness of COVID-19 vaccination is critical for understanding if the
vaccinated population, especially the elderly, is adequately protected from the emergence of …

[HTML][HTML] Vaccines reduced hospital length of stay and fraction of inspired oxygen of COVID-19 patients: A retrospective cohort study

X Fang, G Tao, H Zhou, Y Zhou - Preventive Medicine Reports, 2024 - Elsevier
Few studies have focused on the evaluation of vaccine effectiveness (VE) in mainland
China. This study was to characterize the VE including the frequent symptoms, laboratory …

Effectiveness of Sinopharm's BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron …

J Belayachi, A Mhayi, H Majidi, E El Fahime, R Abouqal - Vaccines, 2024 - mdpi.com
Objective: This study investigates the effectiveness of the 1st booster dose against COVID-
19 severe and critical hospitalizations and deaths occurring due to the Omicron wave in …

Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai

B Zheng, B Gonçalves, P Deng, W Wang, J Tian… - medRxiv, 2024 - medrxiv.org
Background In many settings, a large fraction of the population has both been vaccinated
against and infected by SARS-CoV-2. Hence, quantifying the protection provided by post …

Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study

K Bodner, L Wang, R Kustra, JC Kwong, B Sander… - medRxiv, 2024 - medrxiv.org
Observational studies are essential for measuring vaccine effectiveness. Recent research
has raised concerns about how a relationship between testing and vaccination may affect …